RxDoctor Payments Data

Kevin Sagers, DO

Orthopaedic Surgery · West Jordan, UTNPI 1194102657

Payments from drug & device makers

What this record shows

This record is dominated by education: $20,914 of the $29,910 with a category attached, or 69.9%. Smith+Nephew accounts for 84.0% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $12,308 and has fallen 98.6% since, to $172 in 2025.

$29,910in general payments, 2019–2025

Across 79 payments — averaging $378.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$25K
  • Ortho Development Corporation$2K
  • Goode Surgical Inc$717
  • Stryker$481
  • Think Surgical, Inc.$207
  • Medtronic$140
  • plus $758 from 15 others

What the payments were for

  • Travel & lodging$5,25218%
  • Food & beverage$3,74413%
  • Education$20,91470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,910 in reported general payments places this provider in the 80th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$80,487
Medicare patients
109
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib89$2,810
Cefadroxil52$1,005
Oxycodone Hcl78$540
Dexamethasone71$525
Methocarbamol55$358
Meloxicam15$97
Tramadol Hcl14$52

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in West Jordan

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →